Momentum Biotechnologies

Momentum Biotechnologies’ goal is to accelerate the design-build-test cycle for our clients’ therapeutic discovery programs through superior CRO services. The core of Momentum’s service solutions is mass spectrometry-based native detection analysis for drug discovery. We help clients identify and characterize leads for novel mechanisms of action such as protein degradation/molecular glues, protein-protein interaction disruption or small molecule binding to proteins & RNA targets (ASMS), and irreversible binding to protein & RNA targets (Covalent Screening). We pride ourselves on rapid turnaround of the highest quality data, thus accelerating the momentum of our clients’ projects.